1 tracked superinvestor hold IMMUNOVANT INC (IMVT), worth $2M combined, led by David Einhorn. Smart money is accumulating IMVT as of the latest 13F filings.
Current price
$41.09
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as…
Market cap
$5.5B
P/E
-10.16
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$45
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$2M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
+1
1 buying · 0 selling
Smart money is net accumulating IMVT: 1 funds added or opened versus 0 trimming. 1 opened a brand-new position.
IMMUNOVANT INC (IMVT) is held by 1 tracked funds worth $2M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to David Einhorn at 0.1% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
This quarter 1 fund opened a brand-new position (David Einhorn), with 0 adding and 0 trimming — a net accumulation signal.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| New buy | 0.1% | $2M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own IMVT?
1 tracked funds hold IMMUNOVANT INC (IMVT), the largest being David Einhorn (Greenlight Capital) at 0.1% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling IMVT?
In the most recent 13F quarter, 1 tracked fund added or opened IMVT and 0 trimmed it, including 1 brand-new position.
How much IMVT do tracked funds hold?
Combined disclosed long exposure to IMVT across tracked superinvestors is $2M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.